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Introduction
A World Health Organization (WHO) report1 suggests that 
there will be a rapid increase in noncommunicable diseases 
(NCDs) over the next seven years, which includes sub-
Saharan Africa. In 2005, the WHO estimated that NCDs 
caused an estimated 35-million deaths, which represents 
60% of all deaths globally. Eight per cent of deaths were 
due to NCDs in low- and middle-income countries, including 
South Africa. The WHO has also projected that over the next 
10 years, the largest increase in deaths from cardiovascular 
disease (CVD), cancer, respiratory disease and diabetes will 
occur in developing countries.1
The burden of NCDs is increasing in both rural and urban 
areas of South Africa, and is foremost in poor people living 
in urban areas.2 Mayosi et al identified risk factors that 
contribute to the increase in NCDs, including  demographic 
changes (the increase in the number of older people in the 
population who are at greater risk of developing NCDs), 
lifestyle choices (tobacco use, inactivity and unhealthy 
diets), changes in dietary intake (the shift in diets in the 
developed world, i.e. that are high in refined sugar and 
flour) and genetic predisposition.2 Urbanisation and the 
rising prevalence of NCDs place greater demands on the 
public health sector, the main provider of health care to poor 
people.
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In 2009, the Medical Research Council in the Western Cape 
mortality profile indicated that NCDs were the main cause 
of mortality in all regions in the province.3 According to the 
Western Cape Burden of Disease Study, in 2004, diabetes, 
strokes and ischaemic heart disease were among the 
leading causes of premature mortality. Diabetes moved up 
from eighth place in 2001 to fifth place in 2004.4 The study 
also found strokes to be a major cause of death. CVD 
was the leading cause of death in men and women in the 
Western Cape province, accounting for 25% of deaths.4 
The prevalence of overweight and obesity was high in the 
province in women (57.1%), and was the highest in men 
(38.4%) in all of the provinces. Similar results were also 
found in other developing countries. The prevalence of 
hypertension in India was 164.18 per 1 000 (16.1%) adults 
in urban areas, and 157.44 per 1 000 (15.7%) adults in rural 
areas.5
Prior to the development of the Western Cape Chronic 
Disease Management (CDM) Policy Framework in 2009, 
NCDs were not prioritised in terms of resource allocation 
and had to compete with other priorities, such as human 
immunodeficiency virus (HIV)/acquired immune deficiency 
syndrome (AIDS), tuberculosis and trauma.6 The CMD 
policy aims to develop and implement a comprehensive 
strategy for chronic disease management. Second to 
human resources (57%), the cost of medicine (19% or 
R132 million) is the biggest expenditure item at Metropole 
District Health Services primary healthcare level.7
The study aimed to determine disease profile and 
prescription costs at 10 primary healthcare facilities in the 
western half of the Cape Town Metropole.
The objectives of the study were as follows: 
•	 To describe and quantify the disease profile of patients 
with chronic diseases attending 10 community health 
centres (CHCs). 
•	 To determine the average cost of acute and chronic 
prescriptions per patient at the CHCs. 
Method
Study design
An analytical, cross-sectional study was conducted in order 
to interpret the cost of the medication in relation to the 
patient disease profileand facility type over a three-month 
period.
Setting
Data were collected over a three-month period at the five 
24-hour CHCs in the in the western half of the Cape Town 
Metropole, i.e. Mitchell’s Plain, Hanover Park, Gugulethu, 
Vanguard and Retreat; three medium-sized eight-hour 
facilities, i.e. Crossroads, Dr Abdurahman and Lotus River 
(served by three or more doctors); and two smaller facilities, 
i.e. Inzama Zabantu and Hout Bay (served by one doctor). 
Sampling
Systematic sampling was used. Patients older than 18 
years of age attending the facilities during the week of the 
study were eligible for inclusion in the study. The duration 
of sample collection was one week at each CHC. Twenty 
per cent of the sample was collected on each week day. 
Estimates of the number of daily consultations per clinic 
were obtained from monthly prescription numbers per CHC 
retrieved from the 2010 South African National Department 
of Health routine monthly report of primary healthcare 
facilities.
Sample size
A sample size of folders (n = 370) was required from each 
CHC for this study. The sample size was based on a desired 
precision of 2% and a 95% confidence interval for this 
proportion of varying chronic conditions in the patients. 
Four hundred folders were sampled in order to account for 
potential missing data or ineligible folders. Therefore, at 
least 80 folders were selected per day per facility for five 
consecutive week days. 
Patients who received medication, i.e. either consulted by 
a clinician or collected a prescription refill, were eligible 
for inclusion in the study. HIV-positive patients received 
medication from a separate budget according to specific 
guidelines, and were thus excluded from the study. 
Patient folders were reviewed over five week days in each 
clinic. The folders of patients attending on the study days 
were collected at the pharmacy and were reviewed the 
following day, and data from the prescription charts and 
medical records extracted. Recorded data included the 
type of visit (acute or chronic prescription) and chronic 
disease diagnosis. The number of folders selected for 
review was systematically selected based on the sample 
size calculated from the pilot study. Data were collected 
by one of the researchers (a pharmacist) and a research 
assistant. A standardised data collection tool was used and 
piloted at one of the study centres to ensure validity and 
reliability.
The cost of the prescriptions was calculated according to 
the Cape Medical Depot price list (Cape Medical Depot 
2012, personal communication, March 15).8
Definitions were as follows:
•	 Acute	 script	 or	 condition: Any condition requiring 
medication for a short period (less than one month) with 
no repeat prescriptions.
•	 Chronic	 script	 or	 condition: Any condition requiring 
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•	 Specific	chronic	disease	categories: Specific identified 
chronic disease categories were diabetes, hypertension, 
asthma/chronic obstructive pulmonary disease (COPD), 
epilepsy, arthritis (rheumatoid, osteoarthritis or gout), 
mental health (schizophrenia, depression, anxiety and 
psychosis), miscellaneous (any other condition, e.g. 
eczema, systemic lupus erythematosus and glaucoma). 
•	 Co-morbid	 script	 or	 conditions: Two or more chronic 
conditions.
Ethical considerations and reporting of results
Ethical approval for the study was obtained from the Ethics 
and Research Committee, Faculty of Health Sciences of the 
University of Cape Town (HREC Ref 161/2011). The Provincial 
Research Committee, directors of the substructures and the 
facility managers of the selected CHCs approved the study. 
Individual patients were not identified and confidentiality of 
the records was assured by extraction of the data from the 
folders at the CHCs where the records were held. Patient 
identities were not captured. 
Data analysis
Data were collected from the folders using a standardised 
template and then captured into Microsoft® Excel® and 
Stata® IC version 10.1, in which all analyses were performed. 
Results
Table I lists the demographic profile of patients attending 
the 10 CHCs.
Four thousand one hundred and eighty-four patients 
were included in the study, of whom 64.7% were female 
and 35.04% male. This ratio was comparable at all the 
CHCs. Retreat CHC had the most males (39.14%) and 
Crossroads CHC the least (30.43). The age of the patients 
ranged from 18-101 years. The age distribution was skewed 
towards older patients. Therefore, patients were arbitrarily 
categorised as being older or younger than 35 years of 
age. Overall, 84.39% of patients were older than 35 years 
and 15.61% younger. The CHCs with the least number of 
patients younger than 35 years of age were Dr Abdurahman 
(7.38%), Mitchell’s Plain (9.05%) and Lotus River (9.35%). 
Most young patients were at Inzama Zabantu (29.43%), 
Hout Bay (28.55%) and Crossroads (24.16%).  
The disease profile of patients with chronic diseases
Table II lists the proportion of patients with chronic and 
acute conditions, and the disease profile of patients with 
chronic diseases.
Hypertension was the most prevalent chronic condition 
(58.96%) across the 10 CHCs, followed by arthritis (21.8%) 
and diabetes (19.67%). Diabetes and hypertension were 
most prevalent at Mitchell’s Plain CHC (28.4% and 69.1%, 
respectively), Dr Abdurahman CHC (26.4% and 66.5%, 
respectively) and Lotus River CHC (26% and 68.7%, 
respectively). The centres with the lowest load for these 
two conditions were Inzama Zabantu CHC (14.4% and 
52.2%, respectively), Hanover Park CHC (15.1% and 
52%, respectively) and Hout Bay CHC (15.7% and 51.4%, 
respectively). Gugulethu CHC also had a low diabetic load 
(15%) and Crossroads CHC a low hypertension load (51%). 
The low prevalence of mental health patients at Inzama 
Zabantu CHC could be explained by the fact that they are 
seen at Crossroads CHC.
Mitchell’s Plain (18.5%) and Inzama Zabantu (5%) were the 
two CHCs with extremes for the prevalence of asthma and 
COPD. We found a relatively high number of patients with 
epilepsy (11.01%) at Gugulethu CHC when compared with 
the other centres. The most patients with arthritis were at 
Table I:  The demographic profile of patients attending the ten community health centres
Facility (CHCs) Gender (%)* Age




Gugulethu 37.24 62.53 7.04 11.74 16.2 23.94 21.13 19.95 18 93
Hanover Park 34.39 65.61 5.37 9.76 16.34 20.98 22.2 25.37 18 89
Mitchell’s Plain 32.84 66.67 3.02 6.03 10.55 27.89 30.4 22.11 18 91
Retreat 39.14 60.86 4.53 6.44 15.27 18.38 26.73 28.64 18 93
Vanguard 37.12 61.94 2.37 7.11 18.96 24.64 27.01 19.91 19 93
Dr Abdurahman 35.15 64.61 1.9 5.48 9.29 18.57 30.95 33.81 18 88
Crossroads 30.43 69.32 8.21 13.53 19.08 25.85 20.77 12.56 18 95
Lotus River 34.13 65.87 1.68 7.67 13.67 20.86 24.46 31.65 18 98
HoutBay 33.41 66.36 7.03 19.44 24.82 22.25 15.69 10.77 18 101
Inzama Zabantu 36.36 63.4 10.07 17.27 22.54 27.1 17.03 6 18 95
Median age 35.04 64.7 5.13 10.48 16.71 23.02 23.6 21.06 18 101
CHCs: community health centres, max: maximum, min: minimum








































Original Research: A snapshot of noncommunicable disease profiles and their prescription costs
46 Vol 56 No 1S Afr Fam Pract 2014
Vanguard CHC (34.9%) and Mitchell’s Plain CHC (35.8%). 
The fewest in this regard were at Inzama Zabantu CHC 
(10.7%) and Crossroads CHC (13%). Retreat CHC had the 
most mental health patients (10.5%), and Inzama Zabantu 
the fewest (0.7%). 
Table III details the proportion of patients with co-morbidities.
Co-morbidities were highest at Mitchell’s Plain CHC 
(71.35%), Dr Abdurahman CHC (70.31%) and Lotus River 
CHC (69.7%). They were lowest at Inzama Zabantu CHC 
(30.87%) and Crossroads CHC (35.5%). The proportion 
of patients with four or more conditions was highest at 
Mitchell’s Plain CHC (9.13%), Lotus River CHC (8.6%) and 
Vanguard CHC (7.33%).
Table IV lists the differences in prescription costs for patients 
with acute and chronic conditions.
The average cost per script was similar at Mitchell’s Plain, 
Retreat, Vanguard, Dr Abdurahman and Lotus River CHCs, 
ranging from R59.79-66.10. Costs were lower at Hanover 
Park, Gugulethu Crossroads and Hout Bay CHCs, i.e. 
R41.49-49.19, and significantly lower at Inzama Zabantu 
CHC at R26.04 (Table IV).When considering the cost of 
scripts for acute conditions only, Lotus River CHC was 
the most expensive with an average cost of R23.99. The 
lowest average costs for prescriptions for acute conditions 
were found at Hanover Park, Retreat Crossroads and 
Inzama Zabantu CHCs, i.e. R11.25-14.06. The upper range 
of average costs for the scripts for chronic conditions 
was R66.96-71.22 at Mitchell’s Plain, Retreat, Vanguard, 
Abdurahman, Lotus River and Hout Bay CHCs. The lower 
range of average prescription costs was R49.62-59.48 at 
Hanover Park, Gugulethu and Crossroads CHCs. It was 
much less at Inzama Zabantu CHC (R30). The average cost 
Table II: Proportion of patients with chronic and acute conditions, and the disease profile of patients with chronic diseases (percentage)
 
Facility (CHCs)
Visit (%) Chronic disease (% of all visits)
Acute Chronic Diabetes Hypertension Asthma/
COPD
Epilepsy Arthritis Mental 
health
Other
Gugulethu 20.37 79.63 14.99 58.55 10.54 11.01 27.63 5.85 34.19
Hanover Park 22.68 77.32 15.12 51.95 16.34 2.93 13.41 6.1 42.93
Mitchell’s Plain 5.19 94.81 28.4 69.14 18.52 4.69 35.8 5.19* 49.63
Retreat 10.02 89.98 19.09 63.25 12.89 4.06 14.8 10.5 46.54
Vanguard 15.13 84.87 19.62 57.45 14.89 6.62 34.99 8.75 46.1
Dr Abdurahman 9.26 90.74 26.37 66.51 10.69 3.8 27.55 5.23 60.33
Crossroads 25.36 74.64 17.39 50.72 8.45 6.04 13.04 9.66 14.49
Lotus River 6.92 93.08 26.01 68.74 15.27 5.25 23.87 8.83 60.38
Hout Bay 34.81 65.19 15.65 51.4 9.11 3.74 16.12 5.84 25
Inzama Zabantu 26.08 73.92 14.35 52.15 5.02 6.46 10.77 0.72* 21.05
Total 17.64 82.36 19.67 58.96 12.14 5.47 21.8 6.67 40.03
CHCs: community health centres, COPD: chronic obstructive pulmonary disease
*: Inzama Zabantu Community Health Centre mental health patients are seen at Crossroads Community Health Centre. A large number of the Mitchells Plain mental health patients attend the 
Westridge Psychiatric Clinic
Table III: Proportion of patients with co-morbidities








Number  of chronic diseases per patient
(% of co-morbidities)
1 2 3 4 or more Total
Gugulethu 340 (79.63) 234 (54.8) 106 (24.82) 133 (31.15) 84 (19.67) 17 (3.98) 427 (100)
Hanover Park 317 (77.32) 206 (50.24) 111 (27.07) 126 (30.73) 75 (18.29) 5 (1.22) 410 (100)
Mitchell’s Plain 384 (94.81) 289 (71.35) 95 (23.46) 154 (38.02) 98 (24.2) 37 (9.13) 405 (100)
Retreat 377 (89.98) 225 (53.7) 152 (36.28) 128 (30.55) 88 (21) 9 (2.15) 419 (100)
Vanguard 359 (84.87) 265 (62.65) 94 (22.22) 136 (32.15) 98 (23.17) 31 (7.33) 423 (100)
Dr Abdurahman 382 (90.74) 296 (70.31) 86 (20.43) 157 (37.29) 114 (27.08) 25 (5.94) 421 (100)
Crossroads 309 (74.64) 147 (35.5) 162 (39.13) 112 (27.05) 33 (7.97) 2 (0.48) 414 (100)
Lotus River 390 (93.08) 292 (69.7) 98 (23.39) 143 (34.13) 113 (26.97) 36 (8.6) 419 (100)
Hout Bay 279 (65.19) 173 (40.42) 106 (24.77) 103 (24.07) 55 (12.85) 15 (3.5) 428 (100)
Inzama Zabantu 309 (73.92) 129 (30.87) 180 (43.06) 111 (26.56) 16 (3.83) 2 (0.48) 418 (100)









































Original Research: A snapshot of noncommunicable disease profiles and their prescription costs
47 Vol 56 No 1S Afr Fam Pract 2014
of a script for an acute condition was significantly cheaper 
than that of a script for a chronic condition at all of the 
facilities (Table IV). 
Figure 1 shows the cost of specific chronic conditions when 
they occurred without other co-morbidities. The average 
cost of a prescription for diabetes mellitus was twice that of 
hypertension, but half that of asthma.
The cost per prescription increased with the number of co-
morbidities (Table V).
Figure 2 demonstrates a strong correlation between the 
number of co-morbid chronic diseases and the increased 
cost of the prescriptions (r = 0.9, p-value < 0.001).
Discussion
The increase in the prevalence of NCDs globally and in 
South Africa highlights the need to gauge the extent of the 
problem and to address it in an appropriate manner. The aim 
of this study was to determine the disease profile of patients 
Table IV: Differences in prescription costs for patients with acute and chronic conditions (in rands)
Facility (CHCs) All prescriptions Patients with acute conditions Patients with chronic conditions p-value*
Average (SD) Median Average (SD) Median Average (SD) Median
Gugulethu 43.23  (61.20) 24.55 18.26 (29.96) 10.46 49.62 (66.34) 30.02 < 0.001
Hanover Park 49.12 (62.44) 25.2 13.81 (16.59) 7.25 59.48 (67.02) 34.41 < 0.001
Mitchell’s Plain 64.88 (87.18) 35.23 16.48 (27.95) 6.46 67.52 (88.55) 37.05 < 0.001
Retreat 65.17 (103.85) 32.56 12.93 (17.24) 7.79 70.99 (107.78) 39.03 < 0.001
Vanguard 59.79 (80.19) 31.5 19.17 (32.62) 10.57 67.04 (83.94) 37.84 < 0.001
Dr Abdurahman 66.10 (91.47) 35.49 15.88 (14.85) 10.06 71.22 (94.43) 38.65 < 0.001
Crossroads 41.49 (81.88) 19.91 11.25 (9.87) 7.74 51.77 (92.41) 27.4 < 0.001
Lotus River 65.01 (69.25) 37.62 23.99 (25.87) 19.82 68.06 (70.49) 40.83 < 0.001
Hout Bay 49.18 (83.20) 22.75 15.88 (14.44) 10.98 66.96 (98.03) 33.3 < 0.001
Inzame Zabantu 26.04 (27.99) 15.5 14.06 (15.72) 8.24 30.22 (30.07) 18.7 < 0.001
Overall 52.98 (78.51) 27.62 15.43 (20.13) 8.99 61.01 (83.84) 33.82 < 0.001
SD: standard deviation
*: A comparison was made between the median of acute prescription costs and the median of chronic prescription costs
Table V: The cost (in rands) of prescriptions for a differing number of chronic diseases
Number of chronic diseases 
per patient
n Prescription cost
Mean SD Median Minimum Maximum
Acute diseases 737 15.43 20.13 8.99 0.34 241.76
1 1 190 45.90 88.53 20.22 0.83 1 403.56
2 1 303 53.95 73.73 31.62 2.16 1 035.84
3 774 82.16 81.15 53.18 5.57 1 052
4 155 117.51 89.57 97.48 12.36 521.29
5 19 138.99 76.45 116.79 15.30 291.04
6 5 175.74 85.19 177.02 70.71 292.71
Total 4 183 52.98 78.51 27.62 0.34 1 403.56
SD: standard deviation
Figure 2: The correlation between prescription costs (in rands) and 
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SD: standard deviation
Figure 1: Average (+ standard deviation) and median prescription 
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attending 10 CHCs in the Western half of the Cape Town 
Metropole and the treatment costs of NCDs at primary care 
level. The results could be used for resource allocation in an 
equitable manner in response to the disease burden.  
Slightly less than two thirds of the study sample was female 
(Table I). This corresponds with the ratio of patients who 
attended health services in 2003.8 A 2000 USA study found 
that 65% of its diabetic sample was female and 30% were 
older than 65 years of age.9 This is in line with a global 
report on the prevalence of diabetes which stated that the 
most important demographic change was an increase in 
the proportion of patients who were older than 65 years of 
age.10 The prevalence of diabetes is slightly higher in men 
than it is in women. This could be because the prevalence 
of diabetes increases with age, and there are more elderly 
women than men in most populations.10,11 Overall, in this 
study, 83% of the patients were older than 35 years of age, 
and the prevalence of diabetes mellitus tended to be lower 
at Crossroads, Inzama Zabantu, Hout Bay and Gugulethu 
CHCs. The number of visits to treat chronic conditions, as 
well as co-morbidities in patients, was also lower at these 
sites.
The ratio of visits for chronic conditions to those for acute 
conditions was 82%:18%, and was even higher at Mitchells 
Plain, Dr Abdurahaman, Retreat  and  Lotus River CHCs. 
The 2003 South African Demographics and Health Survey 
found that the most frequently prescribed drugs were 
for hypertension (52 %), asthma and COPD (16%), and 
diabetes and arthritis (just less than 12% each).8 These 
figures were 58.5% for hypertension, 19.4% for diabetes, 
14.1% for asthma and COPD, and 21.8% for arthritis (Table 
II) in our study sample. The higher prevalence of arthritis 
observed at Mitchells Plan and Vanguard CHCs could be 
owing to the rheumatology services that are offered at the 
CHCs, referrals from other CHCs and down referrals from 
hospitals.
In our study, it was found that 65% of patients with chronic 
conditions had co-morbidities and other chronic diseases 
(Table III). This level of co-morbidity was much higher 
than that in a 2002 study which was conducted in the 
Netherlands and which found that in people over the age 
of 65 years, 23% had more than one chronic disease.12 
Patients with osteoarthritis and diabetes mellitus had the 
highest rates of co-morbidity. In 2006, a Swedish study 
found that the variation in individual patient costs was 
substantially different within different age groups, as well as 
within different co-morbidity groups.13 37.7% of individual 
patient costs in the Swedish study could be explained by 
co-morbidities, while age and gender accounted for an 
additional 0.8%.
The cost of prescriptions for chronic diseases was 
significantly higher than the cost for acute conditions at all 
10 facilities (Table IV).The costs of specific chronic conditions 
were difficult to quantify because of the frequent occurrence 
of co-morbidities. Figure 1 represents the cost of specific 
chronic conditions when they occurred without any other 
co-morbidity. The cost per prescription increased with the 
number of co-morbidities (Table V). The 2011 World Bank 
report14 recommended that in order to implement effective 
NCD interventions, primary care needs to be reshaped from 
an acute to a chronic care model, while retaining a strong 
focus on prevention.
Conclusion
The study findings indicate that most adults attending 
public sector facilities in the western half of the Cape 
Town Metropole had chronic conditions, and that the cost 
of treating these conditions was significantly greater than 
that of treating acute conditions. It must be understood that 
interventions in single-disease intervention studies may not 
be effective in our setting because of the high degree of co-
morbidity in patients with chronic conditions.
An integrated approach to the management of chronic 
conditions is important in low-resource settings for the 
efficient utilisation of limited resources. Further research 
is needed to analyse the cost of prescriptions in relation 
to quality-of-care indicators, and to compare prescription 
patterns for specific chronic conditions with prescription 
patterns advocated by national guidelines.
Limitations 
Systematic sampling was used at all of the CHCs, and this 
worked well at the eight-hour facilities. However, there could 
have been an underestimation of the number of acute cases 
from trauma after hours at the 24-hour facilities. This may 
have skewed the data, giving an overestimation of chronic 
conditions.
Sampling was carried out on five consecutive days at 
each clinic. If specialist clinics were operational during 
this time, the prescriptions would not reflect the norm. For, 
example, at Inzama Zabantu CHC, an eye clinic resulted 
in an increase in the number of eyedrops being prescribed 
that day. Monthly or weekly psychiatry clinics during the 
data collection period could also have resulted in more 
psychiatric prescriptions being recorded, thus skewing the 
data.
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